These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33986128)

  • 1. Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease.
    Shambrook P; Hesters A; Marois C; Zemba D; Servan J; Gaymard B; Pico F; Delorme C; Lubetzki C; Arnulf I; Psimaras D; Honnorat J; Gales A; Méneret A
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 33986128
    [No Abstract]   [Full Text] [Related]  

  • 2. Teaching Video NeuroImages: Anti-IgLON5 Disease: A Long-Course Presentation With a Response to Immunotherapy.
    Villacieros-Álvarez J; Ordás CM; Torres-Gaona G; Díez-Barrio A; Prieto-Jurczynska C; Gaig C
    Neurology; 2021 Jun; 96(23):e2901-e2902. PubMed ID: 33361260
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-IgLON5 disease with distinctive brain MRI findings responding to immunotherapy: A case report.
    Pi Y; Zhang LL; Li JC
    Medicine (Baltimore); 2021 Jan; 100(4):e24384. PubMed ID: 33530233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to immunotherapy in a 20-month-old boy with anti-NMDA receptor encephalitis.
    Wong-Kisiel LC; Ji T; Renaud DL; Kotagal S; Patterson MC; Dalmau J; Mack KJ
    Neurology; 2010 May; 74(19):1550-1. PubMed ID: 20458074
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoimmune Encephalitides and Rapidly Progressive Dementias.
    Wesley SF; Ferguson D
    Semin Neurol; 2019 Apr; 39(2):283-292. PubMed ID: 30925620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular Motor Abnormalities in Anti-IgLON5 Disease.
    Macher S; Milenkovic I; Zrzavy T; Höftberger R; Seidel S; Berger-Sieczkowski E; Berger T; Rommer PS; Wiest G
    Front Immunol; 2021; 12():753856. PubMed ID: 34659261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the Clinical Spectrum of IgLON5-Syndrome.
    Wenninger S
    J Neuromuscul Dis; 2017; 4(4):337-339. PubMed ID: 29103046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-NMDA encephalitis: an uncommon, autoimmune mediated form of encephalitis.
    Azizyan A; Albrektson JR; Maya MM; Pressman BD; Moser F
    J Radiol Case Rep; 2014 Aug; 8(8):1-6. PubMed ID: 25426239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune Encephalitis With Elevated N-Type Calcium Channel Antibodies Presenting as Psychotic Depression.
    Simutis CB; Brosch JR; Cunningham AF
    Prim Care Companion CNS Disord; 2020 May; 22(3):. PubMed ID: 32408401
    [No Abstract]   [Full Text] [Related]  

  • 10. Peculiar EEG signatures, ictal drinking and long-term follow-up in anti-LGI1 encephalitis.
    Vogrig A; Pauletto G; Lettieri C; Valente M; Gigli GL
    Neurol Sci; 2019 Jul; 40(7):1503-1505. PubMed ID: 30734134
    [No Abstract]   [Full Text] [Related]  

  • 11. Sleep disorders in autoimmune encephalitis.
    Muñoz-Lopetegi A; Graus F; Dalmau J; Santamaria J
    Lancet Neurol; 2020 Dec; 19(12):1010-1022. PubMed ID: 33212053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible Autoimmune Encephalitis with Claustrum Sign in case of Acute SARS-CoV-2 Infection.
    Ayatollahi P; Tarazi A; Wennberg R
    Can J Neurol Sci; 2021 May; 48(3):430-432. PubMed ID: 32938510
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of Movement Disorder Emergencies in Autoimmune Encephalitis in the Neurosciences ICU.
    Ali F; Wijdicks EF
    Neurocrit Care; 2020 Feb; 32(1):286-294. PubMed ID: 31732848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitis.
    Scheibe F; Ostendorf L; Reincke SM; Prüss H; von Brünneck AC; Köhnlein M; Alexander T; Meisel C; Meisel A
    J Neurol; 2020 Feb; 267(2):317-323. PubMed ID: 31630242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal CSF Findings in Autoimmune Encephalitis-A Monocentric Cohort Study.
    Zrzavy T; Höftberger R; Wimmer I; Berger T; Rommer P; Macher S
    Front Immunol; 2021; 12():646940. PubMed ID: 33828556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overinterpretation and Overtreatment of Low-Titer Antibodies Against Contactin-Associated Protein-2.
    Bien CG
    Front Immunol; 2018; 9():703. PubMed ID: 29696018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoimmune synaptic encephalitis is a disease entity on the rise].
    Modvig S; Høi-Hansen CE; Uldall P; Somnier F
    Ugeskr Laeger; 2012 May; 174(21):1452-6. PubMed ID: 22640785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extreme delta - With or without brushes: A potential surrogate marker of disease activity in anti-NMDA-receptor encephalitis.
    Steriade C; Hantus S; Moosa ANV; Rae-Grant AD
    Clin Neurophysiol; 2018 Oct; 129(10):2197-2204. PubMed ID: 29580710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease.
    Gaig C; Ercilla G; Daura X; Ezquerra M; Fernández-Santiago R; Palou E; Sabater L; Höftberger R; Heidbreder A; Högl B; Iranzo A; Santamaria J; Dalmau J; Graus F
    Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):. PubMed ID: 31454761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Presentation of the Acute Airway: Anti-IgLON5 Disease.
    Chen J; Vasani S
    Laryngoscope; 2021 Mar; 131(3):E724-E726. PubMed ID: 32750166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.